ÂÜÀòÂÒÂ×

Robert Roscow is the Chief Science Officer of Mydecine. As a highly educated geneticist, he has spent his academic and professional careers looking for valuable and unique medicinal molecules found in nature. The last two companies that Mr. Roscow applied his innovations to were Canopy Growth and Ebbu, where he ran their genetics divisions. Mr. Roscow has already leveraged expertise in genomics, evolution, and molecular biology to maximize the industrial production of cannabinoids and their use in a pharmacological context. This work has resulted in multiple patent filings and accolades in publications ranging from Nature to Rolling Stone. Now, Mr. Roscow has set his focus on the vast healing potential of fungi.